Insulin Biosimilar MarketThe global insulin biosimilar market is on track for significant expansion, with an estimated valuation of approximately USD 3,008.0 million in 2024. Exhibiting a year-on-year ...

Explore the lives of India's most successful entrepreneurs. Learn about their journeys, challenges, and contributions to the ...

As of 10:06 AM GMT+5:30. Market Open.

On Sept. 13, Zydus Lifesciences signed a pact with US-based Viwit Pharmaceuticals for two MRI injectables and contrast agents. The pact has been inked for gadobutrol injection, a generic version of ...

Dividend announcements are not available. No other corporate actions details are available.

The Capital Structure page of Biocon Ltd. presents the Authorized Capital, Issued Capital, and Paid-Up Equity Capital of the company over the period.